AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...
T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback